125 related articles for article (PubMed ID: 22850702)
21. Targeted hyperthermia after selective embolization with ferromagnetic nanoparticles in a VX2 rabbit liver tumor model.
Sun H; Xu L; Fan T; Zhan H; Wang X; Zhou Y; Yang RJ
Int J Nanomedicine; 2013; 8():3795-804. PubMed ID: 24124367
[TBL] [Abstract][Full Text] [Related]
22. Lipiodol solution of 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: preclinical study in a rabbit liver cancer model.
Paeng JC; Jeong JM; Yoon CJ; Lee YS; Suh YG; Chung JW; Park JH; Chung JK; Son M; Lee MC
J Nucl Med; 2003 Dec; 44(12):2033-8. PubMed ID: 14660730
[TBL] [Abstract][Full Text] [Related]
23. [The effects of lipiodol-hydroxyapatite nanoparticle on apoptosis, proliferation, and angiogenesis in hepatic tumor: experiment with rabbits].
Sun ZG; Chen XP; Huang ZY; Yang GH; Guan J; Hu DY; Mu LD; Xia XG; Li GP; Zhang WG; Li Z
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):409-13. PubMed ID: 17456384
[TBL] [Abstract][Full Text] [Related]
24. Arterial embolization hyperthermia using As2O3 nanoparticles in VX2 carcinoma-induced liver tumors.
Yu H; Zhu GY; Xu RZ; Niu HZ; Lu Q; Li GZ; Wang ZY; Zhang DS; Gu N; Teng GJ
PLoS One; 2011 Mar; 6(3):e17926. PubMed ID: 21448278
[TBL] [Abstract][Full Text] [Related]
25. [Adriamycin thermotherapy through hepatic artery for model of VX2 carcinoma in rabbit liver].
Zhang HX; Liu Y; Cao W; Wang ZM; Guo WP; Ni DH; Liu YY; Wang YQ; Li WX; Fan AL; Han RY
Ai Zheng; 2002 Aug; 21(8):843-5. PubMed ID: 12478889
[TBL] [Abstract][Full Text] [Related]
26. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
[TBL] [Abstract][Full Text] [Related]
27. A comparison of Re-188-MN-16ET-lipiodol and transcatheter arterial chemoembolization in the treatment of hepatoma: an animal study.
Lin WY; Luo TY; Tsai SC; Kao CH; Tang IC; Huang PW
Nucl Med Biol; 2013 Apr; 40(3):437-41. PubMed ID: 23352603
[TBL] [Abstract][Full Text] [Related]
28. Antitumor effect of miriplatin-lipiodol suspension/emulsion using a VX2 liver tumor model.
Tomozawa Y; Nitta N; Ohta S; Otani H; Watanabe S; Sonoda A; Tsuchiya K; Nitta-Seko A; Takahashi M; Murata K
Jpn J Radiol; 2013 Oct; 31(10):662-7. PubMed ID: 23828788
[TBL] [Abstract][Full Text] [Related]
29. [Expression of MT1-MMP and its significance in rabbit VX2 tumor tissues after transarterial embolization with hydroxyapatite nanoparticles].
Xu T; Chen XP; Guo YX; Li D; Lu L; Huan GZ; Zhang WG
Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(8):606-9. PubMed ID: 18844058
[TBL] [Abstract][Full Text] [Related]
30. Antitumor activity of zinostatin stimalamer (YM881) in human hepatoma cell lines and VX2 liver tumor-bearing rabbits.
Tanaka S; Fujihara A; Yamamoto M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H; Numasaki Y; Konno T
Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):155-63. PubMed ID: 8774069
[TBL] [Abstract][Full Text] [Related]
31. Antitumoural hydroxyapatite nanoparticles-mediated hepatoma-targeted trans-arterial embolization gene therapy: in vitro and in vivo studies.
Li G; Ye L; Pan J; Long M; Zhao Z; Yang H; Tian J; Wen Y; Dong S; Guan J; Luo B
Liver Int; 2012 Jul; 32(6):998-1007. PubMed ID: 22340582
[TBL] [Abstract][Full Text] [Related]
32. BCRP expression in VX2 rabbit liver tumours and its effects on tumour recurrence, metastasis and treatment tolerability.
Li CX; Zhang K; Xie FB
Asian Pac J Cancer Prev; 2013; 14(9):5089-93. PubMed ID: 24175781
[TBL] [Abstract][Full Text] [Related]
33. Image-guided thermal therapy with a dual-contrast magnetic nanoparticle formulation: A feasibility study.
Attaluri A; Seshadri M; Mirpour S; Wabler M; Marinho T; Furqan M; Zhou H; De Paoli S; Gruettner C; Gilson W; DeWeese T; Garcia M; Ivkov R; Liapi E
Int J Hyperthermia; 2016 Aug; 32(5):543-57. PubMed ID: 27151045
[TBL] [Abstract][Full Text] [Related]
34. Symptomatic pulmonary lipiodol embolism after transarterial chemoembolization for hepatic malignant tumor: clinical presentation and chest imaging findings.
Xu H; Yang R; Wang X; Zhu X; Chen H
Chin Med J (Engl); 2014; 127(4):675-9. PubMed ID: 24534221
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of transarterial embolization with arsenic trioxide oil emulsion in a rabbit VX2 liver tumor model.
Kim HJ; Shin JH; Kim TH; Kim EY; Park YS; Park CS; Song HY
J Vasc Interv Radiol; 2009 Oct; 20(10):1365-70. PubMed ID: 19713126
[TBL] [Abstract][Full Text] [Related]
36. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
[TBL] [Abstract][Full Text] [Related]
37. Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation.
Behm B; Di Fazio P; Michl P; Neureiter D; Kemmerling R; Hahn EG; Strobel D; Gress T; Schuppan D; Wissniowski TT
Gut; 2016 Jan; 65(1):134-43. PubMed ID: 25524262
[TBL] [Abstract][Full Text] [Related]
38. [Research of beta-elemene interventional treatment on VX2 carcinoma transplanted on kidney in rabbits].
She JJ; Wang ZM; Che XM; Pan CE
Zhong Xi Yi Jie He Xue Bao; 2006 Nov; 4(6):611-4. PubMed ID: 17090378
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary lipiodol embolism after transcatheter arterial chemoembolization for hepatocellular carcinoma: a case report and literature review.
Naorungroj T; Naksanguan T; Chinthammitr Y
J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S270-5. PubMed ID: 23590054
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the anti-tumor effects of two platinum agents (miriplatin and fine-powder cisplatin).
Watanabe S; Nitta N; Ohta S; Sonoda A; Otani H; Tomozawa Y; Nitta-Seko A; Tsuchiya K; Tanka T; Takahashi M; Murata K
Cardiovasc Intervent Radiol; 2012 Apr; 35(2):399-405. PubMed ID: 21584842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
